These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 16828595)

  • 1. Efficacy of azimilide for the maintenance of sinus rhythm in patients with paroxysmal atrial fibrillation in the presence and absence of structural heart disease.
    Kerr CR; Connolly SJ; Kowey P; Page RL; Pritchett EL; Ruda MY; Ruzyllo W; Wilkinson WE;
    Am J Cardiol; 2006 Jul; 98(2):215-8. PubMed ID: 16828595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiarrhythmic efficacy of azimilide in patients with atrial fibrillation. Maintenance of sinus rhythm after conversion to sinus rhythm.
    Pritchett EL; Kowey P; Connolly S; Page RL; Kerr C; Wilkinson WE;
    Am Heart J; 2006 May; 151(5):1043-9. PubMed ID: 16644334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azimilide for the treatment of atrial fibrillation, atrial flutter, and paroxysmal supraventricular tachycardia: results of a randomized trial and insights on the concordance of symptoms and recurrent arrhythmias.
    Page RL; Pritchett EL; Connolly S; Wilkinson WE;
    J Cardiovasc Electrophysiol; 2008 Feb; 19(2):172-7. PubMed ID: 17916138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic effects of azimilide in atrial fibrillation: efficacy and dose-response. Azimilide Supraventricular Arrhythmia Program 3 (SVA-3) Investigators.
    Pritchett EL; Page RL; Connolly SJ; Marcello SR; Schnell DJ; Wilkinson WE
    J Am Coll Cardiol; 2000 Sep; 36(3):794-802. PubMed ID: 10987602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of azimilide on heart rate and ECG conduction intervals during sinus rhythm in patients with a history of atrial fibrillation.
    Pritchett EL; Schulte MC; Schnell D; Marcello SR; Wilkinson WE; Page RL; Connolly SJ;
    J Clin Pharmacol; 2002 Apr; 42(4):388-94. PubMed ID: 11936563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azimilide vs. placebo and sotalol for persistent atrial fibrillation: the A-COMET-II (Azimilide-CardiOversion MaintEnance Trial-II) trial.
    Lombardi F; Borggrefe M; Ruzyllo W; Lüderitz B;
    Eur Heart J; 2006 Sep; 27(18):2224-31. PubMed ID: 16935870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of azimilide in the treatment of atrial fibrillation in the presence of left ventricular systolic dysfunction: results from the Azimilide Postinfarct Survival Evaluation (ALIVE) trial.
    Pratt CM; Singh SN; Al-Khalidi HR; Brum JM; Holroyde MJ; Marcello SR; Schwartz PJ; Camm AJ;
    J Am Coll Cardiol; 2004 Apr; 43(7):1211-6. PubMed ID: 15063432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-response relations of azimilide in the management of symptomatic, recurrent, atrial fibrillation.
    Connolly SJ; Schnell DJ; Page RL; Wilkinson WE; Marcello SR; Pritchett EL
    Am J Cardiol; 2001 Nov; 88(9):974-9. PubMed ID: 11703992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic effects of azimilide in paroxysmal supraventricular tachycardia: efficacy and dose-response.
    Page RL; Connolly SJ; Wilkinson WE; Marcello SR; Schnell DJ; Pritchett EL;
    Am Heart J; 2002 Apr; 143(4):643-9. PubMed ID: 11923801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azimilide for atrial fibrillation: clinical trial results and implications.
    Pritchett EL; Marcello SR
    Card Electrophysiol Rev; 2003 Sep; 7(3):215-9. PubMed ID: 14739716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptoms at the time of arrhythmia recurrence in patients receiving azimilide for control of atrial fibrillation or flutter: results from randomized trials.
    Connolly SJ; Schnell DJ; Page RL; Wilkinson WE; Marcello SR; Pritchett EL;
    Am Heart J; 2003 Sep; 146(3):489-93. PubMed ID: 12947368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymptomatic or "silent" atrial fibrillation: frequency in untreated patients and patients receiving azimilide.
    Page RL; Tilsch TW; Connolly SJ; Schnell DJ; Marcello SR; Wilkinson WE; Pritchett EL;
    Circulation; 2003 Mar; 107(8):1141-5. PubMed ID: 12615792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the novel antiarrhythmic agent azimilide on experimental atrial fibrillation and atrial electrophysiologic properties.
    Nattel S; Liu L; St-Georges D
    Cardiovasc Res; 1998 Mar; 37(3):627-35. PubMed ID: 9659446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II-antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial.
    Goette A; Schön N; Kirchhof P; Breithardt G; Fetsch T; Häusler KG; Klein HU; Steinbeck G; Wegscheider K; Meinertz T
    Circ Arrhythm Electrophysiol; 2012 Feb; 5(1):43-51. PubMed ID: 22157519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic management of atrial fibrillation: current therapeutic strategies.
    Lévy S
    Am Heart J; 2001 Feb; 141(2 Suppl):S15-21. PubMed ID: 11174354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group.
    Torp-Pedersen C; Møller M; Bloch-Thomsen PE; Køber L; Sandøe E; Egstrup K; Agner E; Carlsen J; Videbaek J; Marchant B; Camm AJ
    N Engl J Med; 1999 Sep; 341(12):857-65. PubMed ID: 10486417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone. A randomized, placebo-controlled study.
    Cotter G; Blatt A; Kaluski E; Metzkor-Cotter E; Koren M; Litinski I; Simantov R; Moshkovitz Y; Zaidenstein R; Peleg E; Vered Z; Golik A
    Eur Heart J; 1999 Dec; 20(24):1833-42. PubMed ID: 10581142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of paroxysmal atrial fibrillation to persistent atrial fibrillation in patients with bradyarrhythmias.
    Saksena S; Hettrick DA; Koehler JL; Grammatico A; Padeletti L
    Am Heart J; 2007 Nov; 154(5):884-92. PubMed ID: 17967594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment Failure With Rhythm and Rate Control Strategies in Patients With Atrial Fibrillation and Congestive Heart Failure: An AF-CHF Substudy.
    Dyrda K; Roy D; Leduc H; Talajic M; Stevenson LW; Guerra PG; Andrade J; Dubuc M; Macle L; Thibault B; Rivard L; Khairy P
    J Cardiovasc Electrophysiol; 2015 Dec; 26(12):1327-32. PubMed ID: 26332293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Department of Veterans Affairs CHF-STAT Investigators.
    Deedwania PC; Singh BN; Ellenbogen K; Fisher S; Fletcher R; Singh SN
    Circulation; 1998 Dec; 98(23):2574-9. PubMed ID: 9843465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.